Logo Logo

Publications by Löffler, H.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 4.

Journal article

Hehlmann, R.; Berger, Ursula; Pfirrmann, Markus; Heimpel, H.; Hochhaus, A.; Hasford, Joerg; Kolb, H. J.; Lahaye, T.; Maywald, O.; Reiter, A.; Hossfeld, D. K.; Huber, C.; Löffler, H.; Pralle, H.; Queisser, W.; Tobler, A.; Nerl, C.; Solenthaler, M.; Goebeler, M. E.; Grieshammer, M.; Fischer, T.; Kremers, S.; Eimermacher, H.; Pfreundschuh, M.; Hirschmann, W. D..; Lechner, K.; Wassmann, B.; Falge, C.; Kirchner, H. H..; Gratwohl, A. (2007): Drug treatment is superior to allografting as first line therapy in chronic myeloid leukemia. In: Blood, Vol. 109, No. 11: pp. 4686-4692

Berger, Ursula; Maywald, O.; Pfirrmann, Markus; Lahaye, T.; Hochhaus, A.; Reiter, A.; Hasford, Joerg; Heimpel, H.; Hossfeld, D. K.; Kolb, H. J.; Löffler, H.; Pralle, H.; Queisser, W.; Hehlmann, R.; Kolb, H.-J. (2005): Gender aspects in chronic myeloid leukemia: long-term results from randomized studies. In: Leukemia, Vol. 19, No. 6: pp. 984-989

Berger, Ursula; Engelich, G.; Maywald, O.; Pfirrmann, Markus; Hochhaus, A.; Reiter, A.; Metzgeroth, G.; Gnad, U.; Hasford, Joerg; Heinze, B.; Heimpel, H.; Hossfeld, D. K.; Kolb, H.-J.; Löffler, H.; Pralle, H.; Queisser, W.; Hehlmann, R. (2003): Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alpha. In: Leukemia, Vol. 17, No. 9: pp. 1820-1826

Hehlmann, R.; Berger, Ursula; Pfirrmann, Markus; Hochhaus, A.; Metzgeroth, G.; Maywald, O.; Hasford, Joerg; Reiter, A.; Hossfeld, D. K.; Kolb, H. J.; Löffler, H.; Pralle, H.; Queisser, W.; Griesshammer, M.; Nerl, C.; Kuse, R.; Tobler, A.; Eimermacher, H.; Tichelli, A.; Aul, C.; Wilhelm, M.; Fischer, J. T.; Perker, M.; Scheid, C.; Schenk, M.; Weiss, J.; Meier, C. R.; Kremers, S.; Labedzki, L.; Schmeiser, T.; Lohrmann, H. P.; Heimpel, H.; Kolb, H.-J.; Lohrmann, H.-P. (2003): Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea. In: Leukemia, Vol. 17, No. 8: pp. 1529-1537

This list was generated on Sun Jun 16 00:30:25 2019 CEST.